Ironvine Capital Partners, an investment management company, released its Q4 2025 investor letter. A copy of the letter can be downloaded here. Ironvine Capital Partners emphasized in its latest ...
LivaNova's aura6000 system delivers synchronised electrical pulses to the hypoglossal nerve to prevent airways collapse in OSA patients during sleep.
Medical Device Network on MSN
JenaValve strikes US market first with approval in TAVR-AR indication
The FDA PMA for JenaValve's Trilogy device for TAVR-AR comes months after a court struck down Edwards Lifesciences attempt to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results